WS #7950

The dominant signal in this window is a flurry of diplomatic activity aimed at de-escalating the Iran crisis, which acts as a counter-signal to the prevailing bearish oil/geopolitical thesis. Multiple sources (Reuters, Al Arabiya, Al Jazeera, and social media) report that Qatar has sent a negotiating team to Tehran in coordination with the U.S., and a draft deal mediated by Pakistan could be announced within hours. This development is corroborated across at least four independent sources, raising its significance. If a deal is reached, it would likely lead to the reopening of the Strait of Hormuz, a sharp drop in oil prices, and a relief rally in equities. Separately, the WHO has escalated the Ebola risk in Congo to 'very high', which could impact biotech and travel stocks. On the corporate front, Futu Holdings received a $271M fine from Chinese regulators, a significant negative for Chinese ADRs. Novo Nordisk's oral Wegovy pill received a positive CHMP opinion for EU approval, a bullish signal for NVO and the obesity drug space. The Iran deal narrative is the highest-significance development and is escalating rapidly.